“Molnupirvir-induced SARS-CoV-2 mutagenesis mechanism and results of this antiviral in patients affected by COVID-19”, RSD, vol. 10, no. 15, p. e231101522916, Nov. 2021, doi: 10.33448/rsd-v10i15.22916.